Symposium to help FSU researchers in life sciences capitalize on entrepreneurial opportunities
Florida State University faculty members, doctoral students and other researchers in the life sciences who are interested in learning how to translate their discoveries in the laboratory into tangible, life-changing products in the marketplace should clear their calendars and head to "The Business of Life Sciences," a free, one-day symposium on Nov. 8.
Sponsored and organized by the Florida State University Office of Intellectual Property Development and Commercialization, the Office of Research and the Life Sciences Faculty Commercialization Roundtable, the program is aimed at faculty members, postdoctoral researchers, doctoral students and alumni in the fields of biology, biomedical sciences, biomedical engineering, biophysics, chemistry and psychology/neuroscience.
"This symposium is intended to spur innovation in the life sciences at FSU," said Lisa Blakley, director of commercialization for the Office of Intellectual Property Development and Commercialization. "Our goal is to transform our basic research strength into leading-edge therapeutics, medical devices and diagnostics. This event is just one of the university's ongoing efforts to provide faculty and Ph.D. students with valuable career development."
The Business of Life Sciences will feature a nationally recognized roster of speakers and panelists. They will assist attendees in exploring the "business" of life science from both scientists' and industry perspectives, Blakley said, noting that the agenda includes top business executives whose careers are directly involved in scientific entrepreneurship, industry research and development, and the commercialization of university research.
The symposium is designed to expose attendees to the field of business from a senior executive's perspective and lay the groundwork for translational research at Florida State.
"Translating FSU's basic research into scientific breakthroughs that help a patient directly can happen best with work across disciplines, industry and the government," said Richard Nowakowski, chairman of the Department of Biomedical Sciences in the College of Medicine and a co-founder of the Life Sciences Faculty Commercialization Roundtable. "Programs such as The Business of Life Science will encourage FSU's researchers to look at their science in a different way and allow them to span boundaries directly to clinicians and ultimately patients."
The Business of Life Sciences symposium will take place:
TUESDAY, NOV. 8
8:30 A.M. – 4 P.M.
(A RECEPTION WILL FOLLOW FROM 4 TO 5:30 P.M.)
AUGUSTUS B. TURNBULL III FLORIDA STATE CONFERENCE CENTER, ROOM 208
555 W. PENSACOLA ST.
The symposium is free, but online registration is required.
Topics will include:
Among the speakers and panelists who will participate in the symposium are:
For more information, email Lisa Blakley at firstname.lastname@example.org.
"Programs such as The Business of Life Science will encourage FSU's researchers to look at their science in a different way and allow them to span boundaries directly to clinicians and ultimately patients."
Florida State University College of Medicine